Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers<subtitle>A pooled analysis of randomized trials</subtitle>
A pooled analysis was conducted of 1257 toddlers who received a fourth dose of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) or Hib conjugate vaccine (Hib polysaccharide conjugated to N. meningitidis outer membrane protein) coa...
Saved in:
Main Authors: | Kristina A. Bryant (Author), Jodie McVernon (Author), Colin D. Marchant (Author), Terry Nolan (Author), Gary S. Marshall (Author), Peter Richmond (Author), Helen Marshall (Author), Michael Nissen (Author), Stephen B. Lambert (Author), Emmanuel Aris (Author), Narcisa Mesaros (Author), Jacqueline M. Miller (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2012-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity and safety of the Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine co-administered with human rotavirus, hepatitis A and 13-valent pneumococcal conjugate vaccines: results from a phase III, randomized, multicenter study in infants
by: Nicola P. Klein, et al.
Published: (2019) -
Fatal meningococcemia due to Neisseria meningitidis serogroup Y in a vaccinated child receiving eculizumab
by: Meltem Polat, et al.
Published: (2018) -
Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies
by: Robert Booy, et al.
Published: (2019) -
Cancer vaccines<subtitle>Are we there yet?</subtitle>
by: Michael G. Hanna, Jr
Published: (2012) -
Reply letter to "Fatal meningococcemia due to Neisseria meningitidis serogroup Y in a vaccinated child receiving eculizumab"
by: Alexandra W. Dretler, et al.
Published: (2018)